Who
Wendy Chung
Director
Company insider
Files Form 4 as: Director, Rallybio; Director, Prime Medicine.
In numbers
- Trades disclosed
- 23
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 1 Aug 2022
- Last trade
- 16 Sep 2026
- Last filed
- 18 Sep 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Sep 2026filed 18 Sep 2026 | RLYB RallybioBiotechnology | SEC FORM 4 Code M | $8,4783,562 at $2.38 | filing |
| 16 Sep 2026filed 18 Sep 2026 | RLYB Rallybiooption or derivative · Biotechnology | SEC FORM 4 Code M | —3,562 at $0.00 | filing |
| 16 Sep 2026filed 18 Sep 2026 | RLYB Rallybiooption or derivative · Biotechnology | SEC FORM 4 Code M | —3,562 at $0.00 | filing |
| 16 Sep 2026filed 18 Sep 2026 | RLYB RallybioBiotechnology | SEC FORM 4 Code M | $8,4783,562 at $2.38 | filing |
| 5 Jun 2026filed 8 Jun 2026 | PRME Prime Medicineoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 5 Jun 2026filed 8 Jun 2026 | PRME Prime Medicineoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 1 Aug 2025filed 5 Aug 2025 | PRME Prime Medicineoption or derivative · Biotechnology | SEC FORM 4 Code D | —13,510 | filing |
| 1 Aug 2025filed 5 Aug 2025 | PRME Prime Medicineoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,510 | filing |
| 1 Aug 2025filed 5 Aug 2025 | PRME Prime Medicineoption or derivative · Biotechnology | SEC FORM 4 Code D | —9,006 | filing |
| 1 Aug 2025filed 5 Aug 2025 | PRME Prime Medicineoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,006 | filing |
| 1 Aug 2025filed 5 Aug 2025 | PRME Prime Medicineoption or derivative · Biotechnology | SEC FORM 4 Code D | —39,062 | filing |
| 1 Aug 2025filed 5 Aug 2025 | PRME Prime Medicineoption or derivative · Biotechnology | SEC FORM 4 Code A | —39,062 | filing |
| 1 Aug 2025filed 5 Aug 2025 | PRME Prime Medicineoption or derivative · Biotechnology | SEC FORM 4 Code D | —45,000 | filing |
| 1 Aug 2025filed 5 Aug 2025 | PRME Prime Medicineoption or derivative · Biotechnology | SEC FORM 4 Code A | —45,000 | filing |
| 4 Jun 2025filed 5 Jun 2025 | PRME Prime Medicineoption or derivative · Biotechnology | SEC FORM 4 Code A | —55,000 at $0.00 | filing |
| 13 May 2025filed 15 May 2025 | RLYB Rallybiooption or derivative · Biotechnology | SEC FORM 4 Code A | —28,500 at $0.00 | filing |
| 12 Jun 2024filed 14 Jun 2024 | PRME Prime Medicineoption or derivative · Biotechnology | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 15 May 2024filed 17 May 2024 | RLYB Rallybiooption or derivative · Biotechnology | SEC FORM 4 Code A | —16,500 at $0.00 | filing |
| 14 Jun 2023filed 16 Jun 2023 | PRME Prime Medicineoption or derivative · Biotechnology | SEC FORM 4 Code A | —39,062 at $0.00 | filing |
| 17 May 2023filed 19 May 2023 | RLYB Rallybiooption or derivative · Biotechnology | SEC FORM 4 Code A | —12,353 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.